EUK 8
Latest Information Update: 14 Jan 2009
Price :
$50 *
At a glance
- Originator Proteome Systems
- Developer Tyrian Diagnostics
- Class Anti-ischaemics; Antidementias; Neuroprotectants; Small molecules
- Mechanism of Action Oxygen radical scavengers; Superoxide dismutase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Adult respiratory distress syndrome; Autoimmune disorders; Myocardial ischaemia; Neurological disorders
Most Recent Events
- 07 Nov 2001 This compound is still in active development
- 23 Jun 1997 Preclinical development for Neurological disorders in USA (Parenteral)
- 06 May 1997 Preclinical development for Adult respiratory distress syndrome in USA (Parenteral)